プロテインアッセイ市場：製品タイプ、用途、エンドユーザー別-2025-2030年世界予測

プロテインアッセイ市場は、2023年に29億8,000万米ドルと評価され、2024年には33億6,000万米ドルに達すると予測され、CAGR 12.82％で成長し、2030年には69億4,000万米ドルに達すると予測されています。

プロテインアッセイは、サンプル中のタンパク質を定量するために設計された分析法であり、医薬品開発、疾病診断、研究など、さまざまな生物学的・製薬学的用途に不可欠です。プロテインアッセイの必要性は、細胞プロセスの基本であるタンパク質の機能と相互作用を理解する上での役割に由来します。バイオテクノロジーやライフサイエンスに広く応用されているこれらのアッセイは、研究機関、診断研究所、製薬会社で利用されています。最終用途の範囲は、バイオセンシング技術による作物の健康分析や環境チェックのための農業にまで広がっています。この市場の主な成長要因としては、慢性疾患の蔓延の増加、診断ツールに対する需要の促進、プロテオミクス研究におけるアプリケーションの拡大などが挙げられます。自動化されたハイスループット・システムなどの技術の進歩は、タンパク質アッセイの有効性を高め、市場の成長を促進します。データ解析のためのAIと機械学習の統合や、ヘルスケア支出と研究資金が増加しているアジア市場にビジネスチャンスがあります。しかし、高度なアッセイ技術に関連する高コストや、タンパク質の安定性や相互作用の取り扱いの複雑さなどの要因によって、市場の成長は制約されています。さらに、厳しい規制ガイドラインは技術革新を遅らせ、市場参入の障壁となります。こうした課題にもかかわらず、アッセイの感度と特異性の向上や環境に優しい試薬の開発には技術革新の機会が存在します。アッセイの精度と効率を向上させる堅牢なバイオインフォマティクス・ツールへの投資は、研究開発にとって実り多い分野です。タンパク質アッセイ市場の競争は激しく、急速に進化しており、技術的進歩とコスト効率の高いソリューションに注力する企業には大きな可能性があります。将来の成長を目指す企業は、研究機関とのコラボレーションを優先し、新規のタンパク質ターゲットやアプリケーションを発見するための探索的研究に投資し、既存の限界に対処しながら、従来のタンパク質アッセイユーティリティの限界を押し広げるべきです。

市場力学：急速に進化するプロテインアッセイ市場の主要市場インサイトを公開

プロテインアッセイ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 製薬業界における迅速な医薬品製造の必要性
  • 民間および政府出資の研究開発プログラムへの高額投資
  • 個人の意識と疾病診断率の向上
• 市場抑制要因
  • 高いインフラコストと低い研究開発収率
• 市場機会
  • プロテオミクス研究の重視の高まり
  • 治療用タンパク質の高度な技術と分析技術
• 市場の課題
  • 厳しい規制の枠組みと訓練された人材の不足

ポーターの5つの力：プロテインアッセイ市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：プロテインアッセイ市場における外部からの影響の把握

外部マクロ環境要因は、プロテインアッセイ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析プロテインアッセイ市場における競合情勢の把握

プロテインアッセイ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスプロテインアッセイ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、プロテインアッセイ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨プロテインアッセイ市場における成功への道筋を描く

プロテインアッセイ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 製薬業界における迅速な医薬品生産の必要性
    • 民間および政府資金による研究開発プログラムへの多額の投資
    • 個人の認識と病気の診断率の向上
  • 抑制要因
    • インフラコストが高く、研究開発の収益が低い
  • 機会
    • プロテオミクス調査の重要性の高まり
    • 治療用タンパク質の高度な技術と分析技術
  • 課題
    • 厳格な規制枠組みと訓練を受けた人材の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 プロテインアッセイ市場：製品別

• 楽器とアクセサリー
• キット
• 試薬

第7章 プロテインアッセイ市場：タイプ別

• 銅イオンベースのアッセイ
• 色素結合アッセイ
• テストストリップベースのアッセイ

第8章 プロテインアッセイ市場：用途別

• 病気の診断
• 医薬品の発見と開発

第9章 プロテインアッセイ市場：エンドユーザー別

• 学術調査機関
• 臨床検査室
• 病院
• 製薬・バイオテクノロジー企業

第10章 南北アメリカのプロテインアッセイ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のプロテインアッセイ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのプロテインアッセイ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abcam Plc
• Bio-Rad Laboratories, Inc.
• BioVision Inc.
• Cell Signaling Technology, Inc
• F. Hoffmann-La Roche Ltd.
• Geno Technology Inc.
• Illumina, Inc
• Lonza Group
• Merck KGaA
• New England Biolabs, Inc.
• Novus Biologicals, LLC
• PerkinElmer Inc.
• Pestka Biomedical Laboratories, Inc.
• QIAGEN GmbH
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. PROTEIN ASSAYS MARKET RESEARCH PROCESS
• FIGURE 2. PROTEIN ASSAYS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PROTEIN ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES PROTEIN ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES PROTEIN ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. PROTEIN ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. PROTEIN ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PROTEIN ASSAYS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PROTEIN ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PROTEIN ASSAYS MARKET DYNAMICS
• TABLE 7. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY COPPER-ION-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY DYE-BINDING ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY TEST STRIP-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PROTEIN ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. CANADA PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. CANADA PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES PROTEIN ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. CHINA PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. CHINA PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. CHINA PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. CHINA PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. INDIA PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. INDIA PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. INDIA PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. INDIA PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. ITALY PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. ITALY PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. ITALY PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. ITALY PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. POLAND PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. POLAND PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. POLAND PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. POLAND PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. QATAR PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. QATAR PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. QATAR PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. QATAR PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM PROTEIN ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM PROTEIN ASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM PROTEIN ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM PROTEIN ASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. PROTEIN ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 192. PROTEIN ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

The Protein Assays Market was valued at USD 2.98 billion in 2023, expected to reach USD 3.36 billion in 2024, and is projected to grow at a CAGR of 12.82%, to USD 6.94 billion by 2030.

Protein assays are analytical methods designed to quantify proteins in a sample, crucial for a variety of biological and pharmaceutical applications including drug development, disease diagnosis, and research. The necessity of protein assays stems from their role in understanding protein functions and interactions, which are fundamental to cellular processes. Broadly applied in biotechnology and life sciences, these assays are utilized by research institutions, diagnostic laboratories, and pharmaceutical companies. The end-use scope extends to agriculture for crop health analysis and environment check-ups through biosensing technologies. Key growth factors in this market include the increasing prevalence of chronic diseases, driving demand for diagnostic tools, and the expanding applications in proteomics research. Advancements in technology, such as automated and high-throughput systems, enhance protein assay efficacy, promoting market growth. Opportunities lie in the integration of AI and machine learning for data analysis and in the Asian markets, with rising healthcare expenditure and research funding. However, market growth is constrained by factors like high costs associated with advanced assay technologies and complexities in handling protein stability and interactions. Additionally, stringent regulatory guidelines can slow innovation and introduce market entry barriers. Despite these challenges, innovation opportunities exist in enhancing sensitivity and specificity of assays and developing eco-friendly reagents. Investing in robust bioinformatics tools to improve assay accuracy and efficiency represents a fruitful area for research and development. The nature of the protein assay market is highly competitive and rapidly evolving, with significant scopes for companies that focus on technological advancements and cost-effective solutions. Businesses aiming to capitalize on future growth should prioritize collaboration with research entities and invest in exploratory studies to discover novel protein targets and applications, addressing existing limitations while pushing the boundaries of conventional protein assay utilities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Protein Assays Market

The Protein Assays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Need for rapid drug productions in pharmaceutical industry
  • High investment in private and government funded research and development programs
  • Increasing awareness and disease diagnoses rate in individuals
• Market Restraints
  • High infrastructure cost and low research & development yields
• Market Opportunities
  • Increasing emphasis on proteomics research
  • Advanced technological and analytical technique for therapeutic protein
• Market Challenges
  • Stringent regulatory framework and lack of trained resources

Porter's Five Forces: A Strategic Tool for Navigating the Protein Assays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Protein Assays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Protein Assays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Protein Assays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Protein Assays Market

A detailed market share analysis in the Protein Assays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Protein Assays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Protein Assays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Protein Assays Market

A strategic analysis of the Protein Assays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Protein Assays Market, highlighting leading vendors and their innovative profiles. These include Abcam Plc, Bio-Rad Laboratories, Inc., BioVision Inc., Cell Signaling Technology, Inc, F. Hoffmann-La Roche Ltd., Geno Technology Inc., Illumina, Inc, Lonza Group, Merck KGaA, New England Biolabs, Inc., Novus Biologicals, LLC, PerkinElmer Inc., Pestka Biomedical Laboratories, Inc., QIAGEN GmbH, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Protein Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Instruments & Accessories, Kits, and Reagents.
• Based on Type, market is studied across Copper-Ion-Based Assays, Dye-Binding Assays, and Test Strip-Based Assays.
• Based on Application, market is studied across Disease Diagnosis and Drug Discovery & Development.
• Based on End-User, market is studied across Academic Research Institutes, Clinical Laboratories, Hospitals, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Need for rapid drug productions in pharmaceutical industry
    • 5.1.1.2. High investment in private and government funded research and development programs
    • 5.1.1.3. Increasing awareness and disease diagnoses rate in individuals
  • 5.1.2. Restraints
    • 5.1.2.1. High infrastructure cost and low research & development yields
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing emphasis on proteomics research
    • 5.1.3.2. Advanced technological and analytical technique for therapeutic protein
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory framework and lack of trained resources
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Protein Assays Market, by Product

• 6.1. Introduction
• 6.2. Instruments & Accessories
• 6.3. Kits
• 6.4. Reagents

7. Protein Assays Market, by Type

• 7.1. Introduction
• 7.2. Copper-Ion-Based Assays
• 7.3. Dye-Binding Assays
• 7.4. Test Strip-Based Assays

8. Protein Assays Market, by Application

• 8.1. Introduction
• 8.2. Disease Diagnosis
• 8.3. Drug Discovery & Development

9. Protein Assays Market, by End-User

• 9.1. Introduction
• 9.2. Academic Research Institutes
• 9.3. Clinical Laboratories
• 9.4. Hospitals
• 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Protein Assays Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Protein Assays Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Protein Assays Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam Plc
• 2. Bio-Rad Laboratories, Inc.
• 3. BioVision Inc.
• 4. Cell Signaling Technology, Inc
• 5. F. Hoffmann-La Roche Ltd.
• 6. Geno Technology Inc.
• 7. Illumina, Inc
• 8. Lonza Group
• 9. Merck KGaA
• 10. New England Biolabs, Inc.
• 11. Novus Biologicals, LLC
• 12. PerkinElmer Inc.
• 13. Pestka Biomedical Laboratories, Inc.
• 14. QIAGEN GmbH
• 15. Thermo Fisher Scientific Inc.